Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
								
																		
									
										
											Công thức hóa học
										
										
											
																						C721H1142N202O204S9																					
									 
																											
																		
									
																											
																		
									
									
																		
																		
																		
									
																		
									
																		
																		
																		
																		
																		
																		
																		
																		
										  
		  
																		
																		
																											
																		
																											
									
											  
		  
								 
							 	
														
															
								 Dược Lực Học : 
								
									Used in the prevention or treatment of oral mucoscitis (mouth ulcers arising from chemotherapy), Kepivance binds to the human keratinocyte growth factor (KGF) receptor on buccal cell surfaces. Kepivance acts as both a cell growth and survival factor by stimulating epithelial cell proliferation, differentiation, and migration around the tongue and mouth. The KGF receptor is found on many tissues particularly around the tongue, esophagus, salivary gland and other gastro-intestinal tract organs.									
							
														
															
								 Cơ Chế Tác Dụng : 
								
									Palifermin is a recombinant human keratinocyte growth factor (KGF). It is 140 residues long, and is produced using E. coli.								
								
									Kepivance binds to the human keratinocyte growth factor (KGF) receptor found on buccal cell surfaces. The binding activates a Ras-MapK (Map kinase) signaling pathway which leads to the transcriptional activation of many proteins important for cell growth and survival.								
							
														
															
								 Dược Động Học  : 
								
									
▧ Half Life : 
Elimination half-life: 4.5 hours (range: 3.3-5.7 hours)								
	
							 
														
														
							
																					
								 Chỉ Định : 
								
									For treatment of oral mucositis associated with chemotherapy and radiation therapy.								
							
	
														
									
							
							
								 Tương Tác Thuốc : 
																
																		
									- 
										Bendamustine
										
											Increases toxicity of bendamustine. Should not be administered within a 24 hour time period of antineoplastic agent administration. 										
									
- 
										Pralatrexate
										
											Increases the toxicity of pralatrexate. Avoid concomitant therapy or do not use palifermin within 24 hours after administration of pralatrexate. 										
									
 								
							
							
							
							
								
								 Liều Lượng & Cách Dùng : 
								
									Powder, for solution - Intravenous								
							
	
							
														
														
							
															
							
							
														
							
						
							
																													
								 Tài Liệu Tham Khảo Thêm 
								
																		
																		
										
											National Drug Code Directory